Arvo, a Brazil-based AI-powered platform designed to identify errors and fraud in healthcare transactions, has raised $4.5 million in a funding round. 

Investors 

The round was led by Canary and K50, with participation from Latitud, Preface, and Endeavor Scale-Up Ventures. 

Founded in 2017, Canary is a venture capital firm based in São Paulo, Brazil. The firm invests in early-stage companies operating in the LATAM region. 

K50 is an early-stage venture capital firm committed to supporting founders who leverage technology to improve access and affordability in the health, finance, and work sectors. Since its inception in 2016, K50 Ventures has invested in over 150 companies. 

Arvo Use of Funds 

The company will use the funds to expand its tech solutions to cover all stages of healthcare transactions, from pre-authorization to final payment. 

About Arvo 

Arvo is a healthtech company that leverages artificial intelligence to ensure the integrity of healthcare transactions. Arvo provides an AI-powered platform that analyzes medical claims data to detect anomalies and inaccuracies. The company’s solutions focus on two main areas: Payment Integrity and Anti-Fraud. To date, Arvo has processed $15 billion in health claims, and its client portfolio includes Porto Saúde, Saúde Petrobras, Athena, and Unimed Nacional. 

Funding Details 

Company: Arvo 

Raised: $4.5M 

Round: Unknown 

Funding Date: September 2024 

Lead Investors: Canary, K50 

Additional Investors: Latitud, Preface, Endeavor Scale-Up Ventures 

Company Website: https://www.arvo.com.br/  

Software Category: Healthcare Payment Integrity and Anti-Fraud 

Source: https://latamlist.com/healthtech-arvo-raised-4-5m-to-avoid-payment-fraud/